Ionis Pharmaceuticals IONS Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnInvestments.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's gain (loss) on disposal of assets?
- Ionis Pharmaceuticals (IONS) reported gain (loss) on disposal of assets of $22.58M in Q1 2026.
- How has Ionis Pharmaceuticals's gain (loss) on disposal of assets changed year-over-year?
- Ionis Pharmaceuticals's gain (loss) on disposal of assets increased by 1143.6% year-over-year, from -$2.16M to $22.58M.
- What is the long-term trend for Ionis Pharmaceuticals's gain (loss) on disposal of assets?
- Over 3 years (2021 to 2024), Ionis Pharmaceuticals's gain (loss) on disposal of assets has grown at a 751.3% compound annual growth rate (CAGR), from -$12K to -$7.4M.
- What does gain (loss) on disposal of assets mean?
- The profit or loss realized from selling company assets.
- How do you interpret gain (loss) on disposal of assets?
- A gain indicates efficient asset management or divestiture of non-core assets, while a loss may indicate asset obsolescence or poor disposal timing.
- How does gain (loss) on disposal of assets compare across companies?
- Standard across all industries; usually treated as a non-operating item in financial analysis.